Green, Adeline Enjema
Anchang-Kimbi, Judith Kuoh
Wepnje, Godlove Bunda
Ndassi, Vicky Daonyle
Kimbi, Helen Kuokuo
Article History
Received: 29 October 2020
Accepted: 16 March 2021
First Online: 12 April 2021
Declarations
:
: Ethical clearance (2019/922-01/UB/SG/IRB/FHS) was obtained from the Faculty of Health Sciences Institutional Review Board the University of Buea, and administrative authorisation from the South West Regional Delegation of Public Health, Buea and District Medical Officer for Tiko Subdivision. Written and verbal informed consent was obtained before enrolment into the study. All participants positive for UGS were freely treated with praziquantel tablets (40 mg/kg of body weight) in collaboration with the local health authorities. Each participant was free to withdraw consent at any time. Identification codes were assigned to each study participant and limited access to study data was maintained to ensure confidentiality.
: Not applicable.
: The authors declare that they have no competing interests.